Evidence-Based Ayurvedic Management of Dyslipidemia : Case Study
DOI:
https://doi.org/10.69980/ajpr.v28i4.855Keywords:
Specific Pathya Measures, Ayurveda, Dyslipidemia, Medovaha Sroto Dushti, Haridra ghan vati , and Shaman ChikitsaAbstract
One of the most prevalent manifestations and a primary contributor to a wide range of lifestyle problems, including pancreatitis, fatty liver, cardiovascular disease, and numerous other conditions, is dyslipidemia. In the Indian population, 25–30% of urban subjects and 15-20% of rural subjects have high cholesterol [1]. Ayurveda states that dyslipidemia is the result of Medovaha srotodushti. For the treatment of dyslipidemia, Nidan Privarjan (removal of causes) and recommendations for particular Pathya measures are helpful. In this instance, we used the aptarpana chikitsa (medovaha srotodushti chikitsa) approach to treat dyslipidemia. Causes of Ruksan, Lekhan, and Ushnagunas Aspatarpan, as medohara and lekhana, the laghu, ruksaguna, katu vipaka, and usnavirya of Haridra are particularly promising. In contemporary medicine, lipid-lowering therapies such as fibrates and statins are well tolerated with less side effects. However, this therapy is typically used for the rest of one's life and adds significantly to the cost of living in underdeveloped nations like India. Thus, for three months, the patient had treatment with Shamana Chikitsa and Kapha-meda Nashak Chikitsa, along with lifestyle adjustments. Through this case study, the authors hope to share their experiences and demonstrate the efficacy of specific Pathya Ahara-Vihara, or Ayurvedic approaches, in the therapy of dyslipidemia.
References
1. ncbi.nlm.nih.gov/pmc/articles/ PMC5485409, By Rajiv Gupta, Ravinder S. Rao, Anup Mishra, on 06 March 2017
2. Prevalence of Dyslipidemia in Urban and Rural India: The ICMR–INDIAB Study, Published: May 9, 2014 https://doi.org/10.1371/journal.pone.0096808
3. Harrison T, Kasper D. Harrison’s principles of internal medicine. New York: McGraw-Hill Medical Publ. Division; 2015.
4. Joshi S, Anjana R, Deepa M, Pradeepa R, Bhansali A, Dhandania V et al. Prevalence of Dyslipidemia in Urban and Rural India: The ICMR–INDIAB Study. PLoS ONE 2014;9(5): e96808.
5. Davidson’s Principle And Practice of Medicine, 22nd Edition, Chapter no16, Page no- 454.
6. Shastri S. Madhav Nidan Utatar Khanda Ch 25 ver.14 Chaukhamba Prakashan, Vranasi. 2013.p.198.
7. Kashinath Shastri and Gorakhnath Chaturvedi, Agnivesha, Charaka Samhita. Sutrasthana 23/5-7, page. No – 437.
8. Comprehensive Review of Haridra and DaruharidraKashaya on Diabetic Retinopathy, GajabhePragati R. MateriaMedica of Ayurda based on MadanpalaNighantu, Vaidya Bhagwan Das. 27. Effects of supplementation with curcuminoids on Dyslipidemia in obese patients a randomized crossover. htt:/pubmed.ncbi.nlm.nih.gov.
9. Kaviraj Govinda Das Sen. Bhaisajyaratnavali. Siddhipada Hindi Commentary, Prof. Siddhinandana Mishra editor. 1st edition. Chapter no-53, Varanasi: Chaukhamba Surbharati Prakashana; 2012,pg 142. . Ibid 23/5-7, p 437.
10. Ibid 21/25-27, page 415. 10. a- Ibid 21/25-28, page 415. b- Ibid 21/25-28, p415.
11. Agnivesh Charak Samhita, Vimanasthana 5/15-16, page713 By Kashinath Shastri & Gorakhnath Chaturvedi.
12. Ibid 27/16, 20,22,23,28.
13. Niranjan, Abhishek & Prof, Dhan. (2008). Chemical constituents and biological activities of turmeric (Curcuma longa L.) -A review. Journal of Food Science and Technology. 45. 109-116.
14. Yang, Qu & Liu, C. & Ren, X. & Zhang, Y. (2013). Chemical constituents from the tuber of Curcuma longa. Journal of China Pharmaceutical University. 44. 207-209.
15. Effects of curcumin/turmeric supplementation on lipid profile: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials Mohammad Jafar Dehzad a , Hamid Ghalandari b , Mohammad Reza Amini c , Moein Askarpour a.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
